Artwork

Treść dostarczona przez Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Player FM - aplikacja do podcastów
Przejdź do trybu offline z Player FM !

It Pays to be Thin

46:18
 
Udostępnij
 

Manage episode 431861552 series 3531512
Treść dostarczona przez Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

In this episode, we tackle some hot topics and share inspiring stories. We start with a big piece of news: the CEO of Novo Nordisk being brought before a Senate committee. This is huge because Novo Nordisk is a major player in the GLP-1 medication world, and there's a lot of scrutiny on how these drugs are priced and covered by insurance.

We also dive into the incredible story of Leslie, who needed a combination of nutrition, exercise, GLP-1 medications, and bariatric surgery to lose an astonishing 157 pounds. Her journey is a powerful reminder that weight loss isn't a one-size-fits-all solution and often requires a multifaceted approach.

On a different note, we discuss some eye-opening research showing that obese people tend to earn less money than their non-obese counterparts. This wage gap is especially pronounced as education levels increase, which is both shocking and troubling.

We also get into the nitty-gritty of insurance coverage for GLP-1 medications. It's frustrating to see how many barriers there are for patients trying to get these potentially life-changing drugs. We offer some tips on how to navigate these challenges and advocate for better coverage.

Overall, this episode is packed with important information and real-life stories that highlight the complexities of weight loss and the broader societal issues related to obesity.

  continue reading

Rozdziały

1. Pay Gap Teaser Clip (00:00:00)

2. Introduction (00:00:38)

3. In the News - Novo Nordisk is Being Brought Before a Senate Committee (00:03:37)

4. Patient Story - Leslie (00:10:34)

5. Nutrition Segment - Habit Change While Actively Losing Weight (00:24:30)

6. The Economics of Obesity - It Pays to be Thin (00:27:54)

7. What to do When Your Insurance Denies You GLP-1 Medications (00:33:54)

8. When to Eat if You Aren't Hungry (00:38:26)

9. How to Handle Hunger Fluctuations While Taking GLP-1's (00:41:23)

45 odcinków

Artwork
iconUdostępnij
 
Manage episode 431861552 series 3531512
Treść dostarczona przez Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Matthew Weiner, MD and Zoe Schroeder, RD, Matthew Weiner, MD, Zoe Schroeder, and RD lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.

In this episode, we tackle some hot topics and share inspiring stories. We start with a big piece of news: the CEO of Novo Nordisk being brought before a Senate committee. This is huge because Novo Nordisk is a major player in the GLP-1 medication world, and there's a lot of scrutiny on how these drugs are priced and covered by insurance.

We also dive into the incredible story of Leslie, who needed a combination of nutrition, exercise, GLP-1 medications, and bariatric surgery to lose an astonishing 157 pounds. Her journey is a powerful reminder that weight loss isn't a one-size-fits-all solution and often requires a multifaceted approach.

On a different note, we discuss some eye-opening research showing that obese people tend to earn less money than their non-obese counterparts. This wage gap is especially pronounced as education levels increase, which is both shocking and troubling.

We also get into the nitty-gritty of insurance coverage for GLP-1 medications. It's frustrating to see how many barriers there are for patients trying to get these potentially life-changing drugs. We offer some tips on how to navigate these challenges and advocate for better coverage.

Overall, this episode is packed with important information and real-life stories that highlight the complexities of weight loss and the broader societal issues related to obesity.

  continue reading

Rozdziały

1. Pay Gap Teaser Clip (00:00:00)

2. Introduction (00:00:38)

3. In the News - Novo Nordisk is Being Brought Before a Senate Committee (00:03:37)

4. Patient Story - Leslie (00:10:34)

5. Nutrition Segment - Habit Change While Actively Losing Weight (00:24:30)

6. The Economics of Obesity - It Pays to be Thin (00:27:54)

7. What to do When Your Insurance Denies You GLP-1 Medications (00:33:54)

8. When to Eat if You Aren't Hungry (00:38:26)

9. How to Handle Hunger Fluctuations While Taking GLP-1's (00:41:23)

45 odcinków

Todos los episodios

×
 
Loading …

Zapraszamy w Player FM

Odtwarzacz FM skanuje sieć w poszukiwaniu wysokiej jakości podcastów, abyś mógł się nią cieszyć już teraz. To najlepsza aplikacja do podcastów, działająca na Androidzie, iPhonie i Internecie. Zarejestruj się, aby zsynchronizować subskrypcje na różnych urządzeniach.

 

Skrócona instrukcja obsługi